Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T08:11:50.337Z Has data issue: false hasContentIssue false

Influence of nutrition on feline calcium oxalate urolithiasis with emphasis on endogenous oxalate synthesis

Published online by Cambridge University Press:  22 February 2011

J. C. Dijcker
Affiliation:
Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584 CL, Utrecht, The Netherlands
E. A. Plantinga*
Affiliation:
Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584 CL, Utrecht, The Netherlands
J. van Baal
Affiliation:
Animal Nutrition Group, Wageningen University, PO Box 338, 6700 AH, Wageningen, The Netherlands
W. H. Hendriks
Affiliation:
Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584 CL, Utrecht, The Netherlands Animal Nutrition Group, Wageningen University, PO Box 338, 6700 AH, Wageningen, The Netherlands
*
*Corresponding author: Dr Esther A. Plantinga, fax +31 30 253 7970, email E.A.Plantinga@uu.nl
Rights & Permissions [Opens in a new window]

Abstract

The prevalence of calcium oxalate (CaOx) uroliths detected in cats with lower urinary tract disease has shown a sharp increase over the last decades with a concomitant reciprocal decrease in the occurrence of struvite (magnesium ammonium phosphate) uroliths. CaOx stone-preventative diets are available nowadays, but seem to be marginally effective, as CaOx urolith recurrence occurs in patients fed these diets. In order to improve the preventative measures against CaOx urolithiasis, it is important to understand its aetiopathogenesis. The main research focus in CaOx formation in cats has been on the role of Ca, whereas little research effort has been directed towards the role and origin of urinary oxalates. As in man, the exogenous origin of urinary oxalates in cats is thought to be of minor importance, although the precise contribution of dietary oxalates remains unclear. The generally accepted dietary risk factors for CaOx urolithiasis in cats are discussed and a model for the biosynthetic pathways of oxalate in feline liver is provided. Alanine:glyoxylate aminotransferase 1 (AGT1) in endogenous oxalate metabolism is a liver-specific enzyme targeted in the mitochondria in cats, and allows for efficient conversion of glyoxylate to glycine when fed a carnivorous diet. The low peroxisomal activity of AGT1 in cat liver is compatible with the view that felids utilised a low-carbohydrate diet throughout evolution. Future research should focus on understanding de novo biosynthesis of oxalate in cats and their adaptation(s) in oxalate metabolism, and on dietary oxalate intake and absorption by cats.

Type
Review Article
Copyright
Copyright © The Authors 2011

Introduction

Urolithiasis is the condition in which calculi are formed in the urinary tract from initially dissolved minerals and/or organic compounds. In domestic cats, the primary stones are composed of calcium oxalate (CaOx) monohydrate or dihydrate and struvite (magnesium ammonium phosphate hexahydrate). Less common stones are purines (i.e. ammonium urate, sodium (calcium) urate, potassium urate, uric acid dihydrate and xanthine), calcium phosphate, matrix, cystine and silica uroliths(Reference Osborne, Lulich and Kruger1).

Urolithiasis in domestic cats is, after feline idiopathic cystitis (FIC), the second most common cause of lower urinary tract disease (LUTD)(Reference Bartges, Kirk and Lane2, Reference Gerber, Boretti and Kley3). Studies with the aim to determine the incidence rates for urolithiasis have not been conducted in cats. Estimates on incidence rates reported in the literature are largely based on morbidity rates seen in veterinary practices, with estimates varying between 0·2 and 0·7 %(Reference Lund, Armstrong and Kirk4, Reference Bartges and Kirk5).

Over the past 30 years, a progressive increase in the prevalence of CaOx uroliths in cats diagnosed with LUTD has been reported in the USA(Reference Osborne, Lulich and Kruger1), with a similar trend being observed in Western Europe(Reference Picavet, Detilleux and Verschuren6). During the early 1980s, CaOx was detected in only 2 % of all feline uroliths submitted to the Minnesota Urolith Center, whereas struvite was detected in 78 % of the uroliths submitted (Fig. 1)(Reference Osborne, Lulich and Kruger1). However, in the mid-1990s, together with a rapid increase in the total number of uroliths submitted for analysis, a notable shift in the submitted types of uroliths has been observed(Reference Buffington and Chew7). In the mid-1980s, the submitted CaOx uroliths noticeably increased(Reference Buffington and Chew8), reaching 55 % in 2002 in the USA(Reference Osborne, Lulich and Kruger1) and 61 % in 2003 in Western Europe(Reference Picavet, Detilleux and Verschuren6). Since 2003 a slight decline in the percentage of CaOx uroliths has been observed, reaching 41 % in 2007. This decline comes along with a reciprocal increase in the frequency of struvite uroliths, up to 49 % in 2007(Reference Osborne, Lulich and Kruger1). The amount of less common uroliths (i.e. purines, calcium phosphate, etc) submitted for analysis has remained fairly constant at about 10 %(Reference Osborne, Lulich and Kruger1). The same general trend in urolith composition can be observed in dogs but is less extreme compared with cats(Reference Osborne, Lulich and Kruger1, Reference Picavet, Detilleux and Verschuren6).

Fig. 1 Feline urolith distribution in the USA from 1981 until 2007(Reference Osborne, Lulich and Kruger1): magnesium ammonium phosphate hexahydrate (□); calcium oxalate (■); calcium phosphate (); purine (); matrix (); other ().

It is generally thought that the concomitant increase in the occurrence of CaOx uroliths with the reciprocal decrease in struvite until 2003 reflects the widespread use of struvite urolith-preventive diets since the mid-1980s(Reference Lekcharoensuk, Osborne and Lulich9, Reference Kirk, Ling and Franti10). These acidifying diets, often with reduced quantities of Mg, are believed to promote calciuria and reduce urinary Mg concentrations, both being risk factors for CaOx urolith formation(Reference Kirk, Ling and Franti10, Reference Lulich and Osborne11). The progressive decrease in occurrence of CaOx uroliths from 2003 until 2007 may be associated with the improvement of adult maintenance and therapeutic diets to minimise risks for CaOx crystalluria.

Despite the use of urolith-preventive diets over the past decades, the prevalence of CaOx uroliths in cats remains substantial. In order to further decrease the incidence of CaOx urolithiasis in cats, understanding of the aetiopathogenesis of CaOx urolithiasis is essential. The purpose of the present review is to discuss dietary risk factors for CaOx urolith formation in cats, with an emphasis on the origin of urinary oxalates. Endogenous biosynthesis of oxalate in the mammalian liver is reviewed and recommendations for research in order to reduce feline CaOx urolithiasis by dietary intervention are provided.

Risk factors

Several risk factors have been identified for CaOx urolith formation in cats. The risk of developing CaOx uroliths appears to increase with age, with cats aged 7–10 years showing the highest predisposition(Reference Lekcharoensuk, Lulich and Osborne12). Other predisposing factors seem to be sex and reproductive status, with male cats more commonly affected (59 %)(Reference Lekcharoensuk, Lulich and Osborne12), and 95 % of cats with CaOx urolithiasis being neutered. However, the imbalance of reproductive status in the population of cats (for example, 78 % of cats examined at primary veterinary practices in the USA were neutered)(Reference Lund, Armstrong and Kirk4) might be a confounding factor. In Burmese, Himalayan and Persian cats, a predisposition to develop CaOx uroliths has been observed, indicating that genetic background also contributes to CaOx urolithiasis(Reference Kirk, Ling and Franti10, Reference Lekcharoensuk, Lulich and Osborne12, Reference Thumchai, Lulich and Osborne13). Nevertheless, considering the short time span in which the types of feline uroliths have changed over the past three decades (Fig. 1), it is highly unlikely that animal-related factors have made a significant contribution to this observed trend, as opposed to nutritional and husbandry factors. Changes in nutrition are thought to be one of the main reasons for the epidemiologic shift in urolith type in cats(Reference Osborne, Lulich and Kruger1).

Urinary concentrations of Ca and oxalate play a key role in CaOx urolith formation. Factors indirectly influencing the formation of CaOx crystals are urinary volume, pH, citrate and glycosaminoglycans (GAG) concentration. The relationship between various dietary components and the risk factors for CaOx urolith formation are outlined in Fig. 2. Dietary components able to influence urine volume, urinary oxalate excretion, urinary Ca excretion, urine pH (acidosis) and urinary citrate and GAG levels (see Fig. 2) will be discussed in more detail.

Fig. 2 Schematic model of dietary risk factors likely to increase calcium oxalate urolith formation in cats. GAG, glycosaminoglycan. * This box contains dietary factors affecting the availability of exogenous oxalate for absorption in the gastrointestinal tract. † This box contains dietary factors affecting endogenous oxalate synthesis.

Urine volume

Theoretically, a high fluid intake could inhibit CaOx urolith formation since it dilutes the urine, thereby lowering the urinary concentrations of Ca and oxalate and, in turn, the crystallisation of CaOx in the urinary tract. Enhancing urine volume may also increase the frequency of urination, which would reduce crystalloid and crystal transit time along the urinary tract, thereby reducing the potential for crystal growth(Reference Markwell, Buffington and Smith14). Therefore, measures to increase water intake to promote high urine volume can be considered as one of the best approaches to prevent urolith recurrence. A higher water intake can be achieved by feeding diets with high moisture and/or Na content.

Dietary factors affecting urine volume

Data in the literature indicate that feeding high-moisture diets to adult cats leads to a slightly higher total water intake leading to an increased urine volume(Reference Gaskell, Rivers and Burger15, Reference Burger and Smith16). When high (82 %)-moisture diets are fed, urine output is increased by 57·4 % compared with low (10 %)-moisture diets(Reference Gaskell, Rivers and Burger15). In a retrospective case–control study with 173 cats with CaOx uroliths, it was found that cats fed (canned) diets containing the highest moisture contents (77·4 to 81·2 %) were only about one-third as likely to develop CaOx uroliths compared with cats fed (dry kibble) diets low in moisture (7·0 to 7·9 %)(Reference Lekcharoensuk, Osborne and Lulich9). The purpose of the latter study was to identify dietary factors associated with the increase in occurrence of CaOx uroliths. The dietary factors studied were moisture content, protein, carbohydrate, fat and fibre content, but also Ca, P, Mg, Na, K and chloride content and urine-acidifying potential. Of these factors, the moisture content of the diet seemed to have the strongest association with CaOx urolith formation in cats(Reference Lekcharoensuk, Osborne and Lulich9). The favourable effect of a high water intake on LUTD in general was also reported by Markwell et al. (Reference Markwell, Buffington and Smith14), who stated that recurrence rates of signs in cats classified as having idiopathic LUTD, or FIC, may be more than halved when affected animals are maintained on high-, rather than low-, moisture content diets. Gunn-Moore & Shenoy(Reference Gunn-Moore and Shenoy17) observed a significantly lower urine specific gravity in cats with FIC when they were fed more canned cat food as well.

The increased water intake when feeding moist diets might not only be due to its higher moisture content, but also because its higher mineral (ash) and protein content (evoking a higher renal solute load) may stimulate drinking(Reference Buffington18, Reference Funaba, Yamate and Hashida19). This is in line with the finding that a high intake of animal protein is accompanied by increased water consumption and urine volume in cats(Reference Funaba, Hashimoto and Yamanaka20). Taking into account the overall beneficial effect of high-moisture diets by increasing urine volume, and therefore diluting all substances dissolved in the urine, feeding a high-moisture diet may be considered as one of the most effective measures to prevent CaOx formation.

Another way to increased urine volume is to stimulate drinking by increasing dietary Na intake(Reference Borghi, Meschi and Schianchi21, Reference Chandler22). This effect of a higher Na intake might explain the results of the previously mentioned retrospective case–control study with 173 cats, in which diets high in Na (0·34 to 0·89 g/MJ metabolisable energy (ME)) were correlated with a decreased risk of CaOx urolith formation(Reference Lekcharoensuk, Osborne and Lulich9). In humans, an increased salt intake has been associated with elevated urinary Ca excretion(Reference Castenmiller, Mensink and van der Heijden23Reference Sakhaee, Harvey and Padalino25). Salt-induced calciuria is believed to result from Na–Ca interactions in the kidney, in both the proximal and distal tubule. Reabsorption of Ca parallels the reabsorption of Na in the proximal tubule and loop of Henle. Na may influence renal reabsorption of Ca in the distal tubule by both a direct effect and indirectly through its effects on parathyroid hormone levels(Reference Massey and Whiting26). In a study with healthy cats, the total daily amount of Ca excreted in urine was reported to be increased(Reference Biourge, Devois and Morice27). Similar results were found in dogs(Reference Lulich, Osborne and Sanderson28, Reference Stevenson, Hynds and Markwell29). However, in two studies with healthy adult cats, dietary Na levels of up to 0·96 g/MJ ME did not increase urine Ca concentrations, but did increase the volume of water drunk, resulting in a larger urine volume and a concomitant decrease in urine specific gravity and CaOx relative supersaturation (RSS)(Reference Hawthorne and Markwell30, Reference Tournier, Aladenise and Vialle31). A possible explanation for this discrepancy might be that an increased dietary Na intake enhances urinary total Ca excretion as seen in humans, but by augmenting urine volume, does not lead to substantially elevated urine Ca concentrations(Reference Lekcharoensuk, Osborne and Lulich9, Reference Biourge, Devois and Morice27).

Overall, research indicates that the urine volume in cats can be increased successfully by feeding a high-moisture diet, as well as by increasing dietary Na intake. An increased Na intake might be used as a preventative measure for CaOx formation as there is no evidence that dietary Na induces elevated Ca concentrations in the urine of healthy cats, and there are no adverse long-term effects reported for this nutrient on, for example, blood pressure and kidney functioning as well(Reference Xu, Laflamme and Long32, Reference Luckschander, Iben and Hosgood33). However, the effectiveness of increased dietary Na intake on reducing CaOx urolith formation in urolith-forming cats has not been tested.

Urinary oxalate

Since oxalate forms a relatively insoluble salt with Ca ions at physiological pH, an increased urinary excretion of oxalate, i.e. hyperoxaluria, can promote CaOx formation. It has been argued that an increase in urinary oxalate concentration promotes CaOx urolith formation to a greater extent than comparable increases in Ca, as changes in urinary oxalate concentration are fifteen times as potent as equimolar changes in Ca concentration in effecting CaOx saturation(Reference Borsatti34, Reference Finlayson35). Therefore, hyperoxaluria is generally accepted as a critical factor of CaOx urolithiasis(Reference Chai, Liebman and Kynast-Gales36). To be able to reduce urinary oxalate excretion, it is essential to understand the origin of the oxalates excreted in the urine of cats. Both the intake of dietary oxalate (exogenous oxalate) and biosynthesis of oxalate (endogenous oxalate) contribute to the amount of oxalate excreted with the urine.

Factors influencing urinary oxalate: exogenous urinary oxalates

Intake of dietary oxalate is a known factor that increases urinary oxalate excretion. The amount of dietary oxalate available for absorption in the gastrointestinal tract is dependent on the amount of free oxalate present in the diet, dietary components which can form complexes with free oxalate (for example, Ca, Mg) and the activity of oxalate-degrading bacteria in the gastrointestinal tract of man and animals.

In general, large amounts of oxalate are present in green leafy vegetables and bran concentrates, moderate amounts in nuts and cereals, and low amounts in dairy products, meat and fish(Reference Massey37, Reference Siener, Honow and Voss38). The contribution of dietary oxalate intake to urinary oxalate excretion in free-roaming cats is unknown, but can be expected to be low, as the natural (carnivorous) diet of the cat is mainly composed of food/prey items that contain low amounts of oxalate(39, Reference Plantinga, Bosch and Hendriks40). In contrast, omnivorous diets (for example, for humans and rats) contain moderate to high levels of oxalate, which may result in a relatively high contribution of exogenous oxalate to total urinary oxalate excretion. In humans, contributions of dietary oxalate to urinary oxalates have been reported, with estimates ranging from 25 to 68 %(Reference von Unruh, Voss and Sauerbruch41, Reference Holmes, Goodman and Assimos42). Unfortunately, no such data are available in cats.

In thirty different dry pet foods for adult small breed dogs, the oxalate content was found to range between 9·6 and 60·0 mg/MJ ME (4–25 mg/100 kcal) with a mean of 26·3 mg/MJ ME (11 mg/100 kcal)(Reference Stevenson, Hynds and Markwell43). In a canned diet designed to assist in the management of LUTD in dogs, the oxalate content was 5·9 mg/MJ ME (2·5 mg/100 kcal)(Reference Stevenson, Blackburn and Markwell44). The average daily intake of oxalate (2·5–15·5 mg/kg body weight (BW) per d) in dogs fed these commercial dry diets can be considered to be relatively high compared with the average oxalate intake (2–3 mg/kg BW per d) by humans(Reference Stevenson, Hynds and Markwell43). Stevenson et al. (Reference Stevenson, Hynds and Markwell43) studied the relative effects of dietary Ca and oxalate on the composition of urine by feeding healthy dogs a diet supplemented with 24·0 to 60·0 mg oxalate/MJ (10–25 mg/100 kcal) and varying the dietary Ca contents. These authors found that the oxalate excretion inconsistently increased with a higher oxalate intake only when dietary Ca intake was low (molar Ca:oxalate ratio <  18). With higher dietary Ca:oxalate ratios (> 25) the oxalate excretion remained low and stable, irrespective of dietary oxalate content. The variation between dogs when different oxalate levels were fed, in conjunction with a low dietary Ca content, was very high, with effects ranging from 0 to a 400 % increase in urinary oxalate excretion. These results indicate that the contribution of dietary oxalate to urinary oxalate excretion in dogs is dependent on the dietary Ca content, and is expected to be low with a high (> 40) molar Ca:oxalate ratio in the diet.

Other factors than dietary Ca are also known to influence intestinal oxalate absorption. A similar role for dietary Mg has been found(Reference Morozumi, Hossain and Yamakawa45). Both minerals can directly interact with oxalate to form an insoluble complex to lower the free oxalate concentration in the gastrointestinal tract(Reference Morozumi, Hossain and Yamakawa45), resulting in a reduction in the absorption of oxalate(Reference Holmes, Goodman and Assimos42, Reference Liebman and Chai46, Reference Liebman and Costa47). Fat and phosphate can act as scavengers for Ca, thereby indirectly increasing the availability of oxalate for uptake by the intestine(Reference Masai, Ito and Kotake48, Reference Naya, Ito and Masai49). In addition, oxalate-degrading bacteria, such as Oxalobacter formigenes present in the intestinal tract of man and rats, are known to reduce the contribution of exogenous urinary oxalates to total urinary oxalates, as this bacterium uses oxalic acid (or its anion oxalate) as its sole energy source by degrading oxalic acid to formate(Reference Sidhu, Allison and Chow50, Reference Troxel, Sidhu and Kaul51). O. formigenes has also been detected in the stool of cats and dogs(Reference Weese and Palmer52, Reference Weese, Weese and Rousseau53). Lactic acid bacteria have also been shown to degrade oxalates in vitro (Reference Weese, Weese and Yuricek54). The impact of oxalate-degrading bacteria in the gastrointestinal tract of humans and animals on urinary oxalate excretion remains to be clarified.

Research in dogs indicates that, although canine foods contain relatively high levels of oxalate, the contribution of exogenous oxalates to the urinary oxalate excretion is expected to be of minor importance mainly due to the high molar Ca:oxalate ratio in commercial canine foods. The influence of factors other than dietary Ca that are known to affect intestinal oxalate absorption in humans is not known in dogs and cats, but is expected to be of minor importance in practice, as the dietary Mg content in the majority of commercial foods is approximately 10-fold lower than the Ca content, and dietary Ca and phosphate are normally balanced. Oxalate and Ca contents of dry commercial feline diets may be expected to be in the same range as canine foods, as similar ingredients are used. This would imply that the potential contribution of exogenous oxalates to total urinary oxalate excretion by domestic cats is expected to be marginal as well, as the Ca:oxalate ratio can be expected to be high. However, the oxalate content of commercial feline foods and its contribution to urinary oxalate excretion remains to be determined in order to ascertain its relative importance.

Factors influencing urinary oxalate: endogenous urinary oxalates

Since hyperoxaluria in humans is recognised as an important risk factor for CaOx urolith formation, many studies (mainly in rodents) have been conducted to unravel the aetiopathogenesis of hyperoxaluria. Studies in human subjects and rodents have revealed that the largest part of the endogenous oxalate formation originates from the conversion of sugars (including glucose and fructose), amino acids (including hydroxyproline, glycine, serine, phenylalanine, tyrosine and tryptophan) and/or glycolate, ending via the metabolism of glyoxylate to oxalate. Another precursor that can give rise to oxalate is ascorbic acid, which can break down non-enzymically in urine to produce oxalate, a reaction which is accelerated at alkaline pH. Originally it was thought that 40 to 50 % of urinary oxalate was derived from the breakdown of ascorbic acid(Reference Holmes, Goodman and Assimos42, Reference Lulich, Osborne and Thumchai55Reference Ogawa, Miyazato and Hatano57). However, close scrutiny of the experimental procedures indicates that the breakdown occurred due to processing of urine at alkaline pH(Reference Holmes, Knight and Assimos58). In cats, ascorbate has not been found to be an important dietary precursor of oxalate(Reference Yu and Gross59), indicating that endogenous oxalate biosynthesis in cats relies predominately on glyoxylate metabolism.

Endogenous biosynthesis of oxalate occurs mainly in the liver(Reference Farinelli and Richardson60) and is highly dependent on the glyoxylate content in the hepatocytes (Fig. 3). Any glyoxylate that is not reduced to glycolate or transaminated to glycine is oxidised to oxalate, a reaction catalysed by cytosolic l-lactate dehydrogenase(Reference Behnam, Williams and Brink61) (Fig. 3(a), step I). Since oxalate can be considered a metabolic ‘end-waste-product’ it will be quantitatively excreted in the urine, mainly via glomerular filtration. Oxalate excretion also occurs in the proximal tubule after a high oral oxalate load(Reference Holmes, Ambrosius and Assimos62, Reference Knight, Holmes and Assimos63). The most efficient way of reducing urinary endogenous oxalate excretion is to reduce the content of glyoxylate in the hepatocyte (Fig. 3). This can be achieved in two ways: by supplying less dietary precursors for glyoxylate production in the hepatocyte or by metabolic removal of glyoxylate from oxalate synthesis.

Fig. 3 Proposed metabolic pathways of de novo oxalate synthesis via glyoxylate metabolism. Major metabolic conversions that are considered prominent in the feline hepatocytes when precursors from a carnivorous and omnivorous diet are present are shown in panels A and B, respectively. Metabolic conversions expected to play a major role are indicated by thick arrows. Metabolic conversions expected to play a minor role are indicated by dashed arrows. Essential metabolic conversions in situation A are indicated with I, II, III or IV, meaning: I, conversion of glyoxylate into oxalate catalysed by cytosolic l-lactate dehydrogenase (l-LDH)(Reference Behnam, Williams and Brink61, Reference Mdluli, Booth and Brady69); II, conversion of glyoxylate into l-glycine catalysed by alanine:glyoxylate aminotransferase 1 (AGT1)(Reference Danpure, Guttridge and Fryer64, Reference Lumb, Purdue and Danpure74, Reference Danpure75, Reference Ribaya and Gershoff82, Reference Takayama, Fujita and Suzuki83, Reference Zentek and Schulz92, Reference Nguyen, Kalin and Drouve100, Reference Noguchi, Okuno and Takada101, Reference Ogawa, Hossain and Ogawa105); III, conversion of glyoxylate into glycolate catalysed by glyoxylate reductase/hydroxypyruvate reductase (GR/HPR)(Reference Mistry, Danpure and Chalmers67, Reference Danpure, Jennings and Mistry68, Reference Mdluli, Booth and Brady69, Reference McKerrell, Blakemore and Heath72, Reference Booth, Conners and Rumsby155, Reference Genolet, Kersten and Braissant156); IV, conversion of hydroxypyruvate into d-glycerate catalysed by glyoxylate reductase/hydroxypyruvate reductase(Reference Mistry, Danpure and Chalmers67, Reference Danpure, Jennings and Mistry68, Reference Mdluli, Booth and Brady69, Reference McKerrell, Blakemore and Heath72, Reference Booth, Conners and Rumsby155, Reference Genolet, Kersten and Braissant156). Essential metabolic conversions in situation B are indicated with Ia–d, II, III and IV, meaning: Ia, conversion of cytosolic d-fructose, d-glucose and d-galactose into d-glycerate(Reference Nguyen, Dumoulin and Henriet86, Reference Nguyen, Dumoulin and Wolf87, Reference Nguyen, Dumoulin and Henriet89); Ib, conversion of d-glycerate into hydroxypyruvate; Ic, conversion of hydroxypyruvate into glycolaldehyde(Reference Gambardella and Richardson80); Id, conversion of glycolaldehyde into glycolate(Reference Gambardella and Richardson80); II, conversion of peroxisomal glycolate into oxalate catalysed by glycolate dehydrogenase (GD)(Reference Yanagawa, Maeda-Nakai and Yamakawa97); III, conversion of peroxisomal glycolate into glyoxylate catalysed by glycolate oxidase (GO)(Reference Yanagawa, Maeda-Nakai and Yamakawa97); IV, conversion of glyoxylate into l-glycine catalysed by alanine:glyoxylate aminotransferase 1(Reference Danpure, Guttridge and Fryer64, Reference Lumb, Purdue and Danpure74, Reference Danpure75, Reference Noguchi, Okuno and Takada101, Reference Xue, Sakaguchi and Fujie157).

Glyoxylate removal can be achieved through the conversion into glycine, which is catalysed by serine:pyruvate aminotransferase/alanine:glyoxylate aminotransferase, also called alanine:glyoxylate aminotransferase 1 (AGT1)(Reference Danpure, Guttridge and Fryer64) (Fig. 3(a), step II). This enzyme can also convert serine into hydroxypyruvate. An essential cofactor for AGT1 is pyridoxine, or vitamin B6. A deficiency in pyridoxine can lead to a shift from glyoxylate removal through conversion into glycine, to glyoxylate oxidation to oxalate. This shift has been well documented in cats. In a study with kittens that were fed a pyridoxine-deficient diet, a significantly higher daily urinary oxalate excretion was observed(Reference Bai, Sampson and Morris65).

Glyoxylate can also be converted into glycolate (Fig. 3(a), step III) via the action of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR), a 2-hydroxy-acid dehydrogenase. GR/HPR also catalyses the reduction of hydroxypyruvate to d-glycerate (Fig. 3(a), step IV) and the oxidation of d-glycerate to hydroxypyruvate(Reference Williams and Smith66). In the human liver, GR/HPR is found predominantly in the cytosol (> 90 %), with a small portion in the mitochondria(Reference Mistry, Danpure and Chalmers67). In cats, GR/HPR localisation has been reported to predominantly occur in the cytosol(Reference Danpure, Jennings and Mistry68).

The existence and importance of the conversions of glyoxylate into glycine and glycolate in the hepatocyte has been discovered as a result of extensive research into two severe autosomal-recessive disorders leading to mild to severe hyperoxaluria in humans. These disorders are termed primary hyperoxaluria (PH) and two types can be distinguished. PH type I is an inherited disorder of glyoxylate metabolism arising from a deficiency in AGT1, leading to a disrupted conversion of glyoxylate into glycine (Fig. 3(a), step II). PH type II is an inherited disease caused by mutations in GR/HPR, leading to a reduced conversion of glyoxylate into glycolate (Fig. 3(a), step III) and that of hydroxypyruvate into d-glycerate (Fig. 3(a), step IV)(Reference Mdluli, Booth and Brady69, Reference Cramer, Ferree and Lin70). PH type II patients have a limited ability to convert d-glycerate into hydroxypyruvate, resulting in most cases in an elevated concentration of l-glycerate in the urine, as metabolic removal of d-glycerate occurs via conversion into l-glycerate (Fig. 3). The reported cases of PH in cats(Reference De Lorenzi, Bernardini and Pumarola71, Reference McKerrell, Blakemore and Heath72) reflect those of human PH type II(Reference Danpure, Jennings and Mistry68), while cases of PH in cats analogous to human PH type I are unknown.

Highly notable is the observation that the spatial localisation of AGT1 seems to be species dependent. In carnivores and insectivores, AGT1 is mainly present in mitochondria(Reference Danpure, Fryer and Jennings73, Reference Lumb, Purdue and Danpure74), while in the human liver an almost exclusive peroxisomal localisation of this enzyme has been reported(Reference Danpure75). The mitochondrial localisation of AGT1 is seen in carnivorous and insectivorous species of different genera (mammals, birds, reptiles)(Reference Danpure, Fryer and Jennings73), indicating that AGT1 localisation in the mitochondrion might be a necessity when consuming high-protein, low-carbohydrate diets. Interestingly, the Gly170Arg in combination with the Pro11Leu mutation in the gene AGXT, encoding for AGT1, which are commonly found in human patients with PH type I, targets AGT1 to mitochondria instead of to its normal location in peroxisomes(Reference Danpure75), resembling the mitochondrial localisation of hepatic AGT1 in carnivores(Reference Lumb, Purdue and Danpure74). Herbivores, such as Old World monkeys (macaques and baboons), rabbits and guinea-pigs, have most, if not all of their AGT1 located in peroxisomes(Reference Lumb, Purdue and Danpure74). Rodents (rats, mice, hamsters) and marmosets (New World monkey) have AGT1 distributed approximately equally between both organelles. The interspecies difference in intracellular localisation of hepatic AGT1 may very well be the result of dietary selection pressure during evolution(Reference Lumb, Purdue and Danpure74).

Genomic expression analyses have revealed that the adaptive shift in AGT1 targeting among species can be ascribed to the use of alternative transcription- and translation-initiation sites of the single-copy AGXT gene(Reference Oatey, Lumb and Danpure76, Reference Birdsey, Lewin and Cunningham77). The longest transcript of AGXT, as found in cats, encodes a cleavable N-terminal mitochondrial targeting sequence (MTS) and C-terminal peroxisomal targeting sequences for peroxisomal uptake, in which MTS is dominant over peroxisomal targeting sequences in determining the final subcellular destination of AGT1(Reference Oatey, Lumb and Danpure76, Reference Birdsey, Lewin and Cunningham77). Species such as man and rabbits expressing AGT1 almost exclusively in peroxisomes have lost the first translation start site during evolution resulting in an MTS-lacking protein. In cats and other species expressing AGT1 almost exclusively in mitochondria, almost all encoded proteins contain the MTS due to the loss of the – more downstream – second transcription-initiation site(Reference Lumb, Purdue and Danpure74, Reference Birdsey, Lewin and Cunningham77). Species in which hepatic AGT1 is roughly equally distributed between both organelles utilise both translation-initiation sites(Reference Purdue, Lumb and Danpure78).

It has been postulated that the dual localisation of AGT1 in the liver is a reflection of its dual physiological function: that is, its role in glyoxylate detoxification in peroxisomes and its role in gluconeogenesis in mitochondria(Reference Danpure, Guttridge and Fryer64, Reference Lumb, Purdue and Danpure74). Intraperoxisomal glyoxylate detoxification is essential in herbivores, since their diet is rich in glycolate and carbohydrates. To prevent oxidation of cytosolic glyoxylate to oxalate by l-lactate dehydrogenase (Fig. 3(a), step I), a high activity of intraperoxisomal AGT1 is required. High levels of glycolate and carbohydrates in combination with a scarcity of animal protein (containing l-hydroxyproline, glycine, serine), typically found in diets of herbivores, retard the need for directing hydroxyproline-derived glyoxylate into gluconeogenesis by conversions facilitated by AGT1 (Fig. 3(a), step II). In contrast, carnivores and insectivores are likely to have consumed a very low amount of glycolate and carbohydrates during evolution and these species have not required intensive detoxification of glyoxylate in the peroxisome. In contrast, the high animal protein and low carbohydrate content of the diet of carnivores and insectivores would clearly favour the contribution of gluconeogenesis in the mitochondrion(Reference Danpure, Guttridge and Fryer64).

As stated earlier, the glyoxylate content in the hepatocyte is also dependent on certain dietary precursors. In human medicine, it has been demonstrated that a high intake of amino acids (i.e. hydroxyproline, serine, glycine, phenylalanine, tyrosine and tryptophan)(Reference Purdue, Lumb and Danpure78Reference Takayama, Fujita and Suzuki83) or sugars (i.e. glucose, fructose, galactose, xylose)(Reference Ribaya-Mercado and Gershoff84Reference Nguyen, Dumoulin and Henriet89) stimulates oxalate synthesis from the intermediate product glyoxylate. Knight et al. (Reference Knight, Jiang and Assimos90, Reference Knight, Easter and Neiberg91) showed that hydroxyproline is a potent contributor to urinary oxalates, with glycine contributing little to the endogenous production of glycolate or oxalate. In cats, the endogenous synthesis of oxalate has not been widely studied. A study by Zentek & Schulz(Reference Zentek and Schulz92) describes the effects of various dietary protein sources (collagen tissue, horse meat and soya isolate) on urine composition, including urinary oxalate excretion. Uptake of the (high)-protein diet with collagen as the protein source resulted in an increase in urinary oxalate excretion (2·83 (sd 0·89) mg/kg BW per d) compared with the (high)-protein diets with horse meat and soya protein isolate as the protein source (0·94 (sd 0·29) mg/kg BW per d and 1·17 (sd 0·53) mg/kg BW per d, respectively). Since the hydroxyproline content of collagen tissue is high (about 10–13 %), mitochondrial AGT1, which converts l-hydroxyproline-derived glyoxylate into glycine (Fig. 3(a), step II), might have been saturated in the cats fed the collagen protein, leading to undesirable conversion to oxalate by l-lactate dehydrogenase (Fig. 3(a), step I), resulting in an increased urinary oxalate excretion(Reference Takayama, Fujita and Suzuki83). Besides hydroxyproline, the amino acids glycine and serine are also present in relatively high concentrations in collagen tissue(Reference Laser Reutersward, Asp and Bjork93).

Zentek & Schultz(Reference Zentek and Schulz92) also investigated the effects of different dietary protein levels on daily urinary oxalate excretion. Of each protein source (collagen tissue, horse meat and soya isolate), two diets were fed, one containing a high and the other a low protein level. In the low-protein diets, protein was exchanged with rice (carbohydrate) and animal fat. Remarkably, all low-protein diets showed a consistently higher daily urinary oxalate excretion. The oxalate excretion increased approximately 5-fold (from 2·83 (sd 0·89) to 13·70 (sd 4·32) mg/kg BW per d) when fed the low-protein diet with collagen as the protein source compared with the high-protein diet. Urinary oxalate excretion increased 4-fold when changing from high- to low-protein diets using soya isolate and horse meat as a protein source (soya isolate diet from 1·17 (sd 0·53) to 4·79 (sd 2·73) mg/kg BW per d and the horse meat diet from 0·94 (sd 0·29) to 3·62 (sd 2·44) mg/kg BW per d). However, the observed increase in urinary oxalate excretion might have been the result of a concomitant high carbohydrate intake with the low-protein diets. As stated earlier, in humans sugars (i.e. glucose, fructose, galactose, xylose) are known to be a substrate for the peroxisomal glyoxylate pathway(Reference Ribaya-Mercado and Gershoff84Reference Nguyen, Dumoulin and Henriet89). It is conceivable that when fed a high-carbohydrate diet, cats suffer an overload of hepatic oxalate as a consequence of a deficiency in peroxisomal AGT1 and excrete more oxalate in their urine. Although the urinary oxalate excretion was found to be unaffected in a study feeding healthy cats a dry commercial diet with a low carbohydrate content (19·1 g/MJ ME) v. a high carbohydrate content (34·7 g/MJ ME)(Reference Mustillo, Bartges and Kirk94), the carbohydrate content of the low-carbohydrate diet in this study can still considered to be high compared with the carbohydrate content of the experimental diets in the study of Zentek & Schultz(Reference Zentek and Schulz92) (i.e. collagen tissue diets: 2·7 v. 23·2 g/MJ ME; soya diets 7·1 v. 22·3 g/MJ ME; horse meat diets 5·9 v. 25·3 g/MJ ME).

A proposed metabolic pathway for the synthesis of the undesirable metabolite oxalate in cats from sugars is presented in Fig. 3(b). In this model, the sugars d-fructose, d-glucose and d-galactose are first converted to d-glycerate (Fig. 3(b), step Ia). Since the activity of fructokinase in feline liver is found to be relatively high and that of glucokinase to be low(Reference Tanaka, Inoue and Takeguchi95), the contribution of d-fructose compared with d-glucose is expected to be higher. d-Glycerate can subsequently be converted into glycolate via the intermediates hydroxypyruvate and glycolaldehyde (Fig. 3(b), steps Ib, Ic and Id). The sugar d-galactose(Reference Ribaya-Mercado and Gershoff84) can also be converted to glycolate, with only glycolaldehyde as an intermediate. The sugar xylose enters the metabolic pathway to oxalate via glycolaldehyde as well(Reference Rofe, Thomas and Edwards96). Cytosolic glycolate may partly be directed into the peroxisomes by diffusion where glycolate will be either oxidised directly to oxalate by the enzyme glycolate dehydrogenase(Reference Gambardella and Richardson80) (Fig. 3(b), step II) or converted to glyoxylate by the enzyme glycolate oxidase(Reference Yanagawa, Maeda-Nakai and Yamakawa97) (Fig. 3(b), step III). In most animals, the major part of this glyoxylate will be transaminated to glycine by AGT1 (Fig. 3(b), step IV) (i.e. peroxisomal glyoxylate detoxification), but in cats, and other carnivores, most of this glyoxylate will probably be converted back to glycolate due to a deficit of AGT1 activity in the peroxisome. This surplus in glycolate will probably result in an increased conversion of glycolate to oxalate catalysed by glycolate dehydrogenase (Fig. 3(b), step II).

An additional explanation for the increase in oxalate synthesis upon feeding diets high in carbohydrate and low in protein content may be a reduction of gluconeogenesis in the liver, which results in a lower need for glycine and serine as a gluconeogenic precursor. It is conceivable that high concentrations of glycine and/or serine attenuate mitochondrial AGT1 in a negative feedback loop. This might result in an additional shift to oxalate synthesis. Collectively, it is possible that in cats a high carbohydrate intake is a potential risk factor for CaOx urolith formation by increasing endogenous oxalate synthesis.

The prevention of oxalate synthesis in cats by expressing AGT1 almost exclusively in the mitochondrion can be considered as one of the many enzymic adaptations as a result of their obligatory carnivorous lifestyle throughout evolution. By expressing AGT1 almost exclusively in the mitochondrion, the formed glyoxylate (mainly originating from hydroxyproline) is efficiently transaminated to glycine (Fig. 3(a), step II), which can directly be used for intramitochondrial gluconeogenesis. This enzymic adaptation appears to be part of a long list of adaptations in this species, such as cysteine dioxygenase and cysteinesulfinate decarboxylase (taurine synthesis), pyrroline-5-decarboxylase and ornithine aminotransferase (citrulline synthesis), dioxygenase (retinol synthesis), glucokinase (glucose metabolism), 7-hydroxycholesterol-Δ7 reductase (25-hydroxycholesterol synthesis) and picolinic carboxylase (nicotinic acid synthesis)(39, Reference Morris98).

Dietary factors influencing endogenous urinary oxalate synthesis

In cats, urinary oxalate excretion has been found to be inversely correlated with protein intake and dependent on the protein source(Reference Zentek and Schulz92), although the inverse correlation with protein intake might be the result of a higher carbohydrate intake. In contrast, in human subjects some studies reported that urinary oxalate excretion increased with increased dietary protein intake and decreased with protein restriction(Reference Curhan, Willett and Rimm99, Reference Nguyen, Kalin and Drouve100). This might be explained by the distinct subcellular AGT1 distribution in humans and cats.

AGT1 catalyses the hepatic transamination of glyoxylate, being an important precursor of oxalate, to glycine(Reference Noguchi, Okuno and Takada101). Pyridoxine, or vitamin B6, is a known cofactor for AGT1(Reference Takada, Mori and Noguchi102) and, as such, pyridoxine deprivation could indirectly elevate endogenous oxalate biosynthesis and, in turn, its urinary excretion(Reference Teerajetgul, Hossain and Yamakawa103Reference Ogawa, Hossain and Ogawa105). Indeed, the daily urinary oxalate excretion was higher in kittens fed a pyridoxine-deficient diet compared with those receiving adequate amounts of pyridoxine(Reference Bai, Sampson and Morris65, Reference Bai, Sampson and Morris106). Moreover, pyridoxine can act as a cofactor for various enzymes in the tricarboxylic acid cycle as well, leading to a decreased synthesis of citrate. Thus, under the condition of pyridoxine deficiency, citrate metabolism may be impaired, leading to a lower urinary citrate concentration and increased risk of precipitation with CaOx(Reference Teerajetgul, Hossain and Yamakawa103). To the authors' knowledge, the effect of pyridoxine on urinary citrate excretion in cats has not been studied.

Although an excess consumption of ascorbate (i.e. vitamin C) has been associated with increased endogenous oxalate synthesis (by the non-enzymic oxidation of ascorbate to oxalate)(Reference Chai, Liebman and Kynast-Gales36, Reference Auer, Auer and Rodgers107Reference Baxmann, De O G Mendonça and Heilberg110) in humans, in healthy cats dietary supplementation with ascorbate up to 193 mg/kg did not affect urinary oxalate concentrations(Reference Yu and Gross59). However, only the effect of a moderate and not a high amount of ascorbate on the urinary oxalate excretion has been tested. As cats, in contrast to man, can synthesise ascorbate in sufficient amounts de novo from glucose, ascorbate is not an essential nutrient(111). Although there is no evidence that dietary ascorbate can increase urinary oxalate levels in cats, it is generally recommended to avoid excessive amounts of dietary ascorbate. This recommendation is purely based on the results obtained in human subjects.

Urinary calcium

It goes without saying that an increase in urinary Ca excretion, as one of the constituents of CaOx uroliths, significantly contributes to CaOx formation. The question is whether hypercalciuria is indeed a causative factor in CaOx uroliths formation. In humans hypercalciuria is thought to be a risk factor for, but not necessarily the cause of, CaOx urolith formation(Reference Bartges, Kirk and Lane2).

One of the factors that can cause hypercalciuria is hypercalcaemia. Approximately 35 % of the cats with CaOx uroliths also have evidence of an increase in total serum Ca concentrations(Reference Osborne, Lulich and Thumchai112). On the other hand, in a study which reported the laboratory findings, clinical course, and treatment of twenty cats with idiopathic hypercalcaemia, 35 % (seven cats) had signs of urolithiasis, and in only two cats these uroliths were composed of CaOx(Reference Midkiff, Chew and Randolph113). Although hypercalcaemia is frequently seen in cats with CaOx urolithiasis, hypercalcaemia in itself does not seem to be a causative factor in CaOx formation.

Another factor that is frequently indicated as a possible cause for hypercalciuria is feeding an acidified diet. In a case report of five cats with hypercalcaemia and CaOx urolithiasis, hypercalcaemia resolved after discontinuation of urinary acidifying therapy or dietary change, or both(Reference McClain, Barsanti and Bartges114). Controlled studies in cats have confirmed that feeding acidifying diets to cats leads to increased urinary Ca excretion. In a long-term case–control study, feeding healthy adult cats an acidifying diet supplemented with 1·7 % phosphoric acid, a low urine pH ( ≤ 6·4) was found, together with an increase in urinary Ca excretion(Reference Fettman, Coble and Hamar115). Another study reported the same effect, with the exception that only after 1 month of feeding an acidifying diet (1·5 % ammonium chloride added), the calciuric response declined gradually (during 4 months)(Reference Ching, Fettman and Hamar116).

Dietary factors influencing urinary calcium excretion

Conflicting results exist in the literature on the role of dietary Ca in inducing and resolving hypercalciuria. For decades, the prevailing consensus was that dietary Ca restriction would reduce urinary Ca excretion, and as such CaOx formation(Reference Lekcharoensuk, Osborne and Lulich9). However, recent literature in humans and dogs indicates that there might be an advantage of increased dietary Ca intake, which is thought to be related to interactions between Ca and oxalate in the intestinal lumen(Reference Stevenson, Blackburn and Markwell44, Reference Penniston and Nakada117). When sufficient dietary Ca is available, complexation with oxalate occurs in the intestinal lumen, which in turn results in a reduction of intestinal absorption and renal excretion of both exogenous Ca and oxalate. Furthermore, a retrospective case–control study in cats revealed that consuming diets with a relatively low amount of Ca (0·23 to 0·49 g/MJ ME) had a significantly greater risk for CaOx urolith formation than cats that consumed higher dietary levels of Ca(Reference Lekcharoensuk, Osborne and Lulich9). This association may be explained by a higher oxalate absorption from the gastrointestinal tract.

Low dietary intake of P may be related to an increased urinary Ca excretion due to a lower binding of Ca by phosphate ions in the gastrointestinal tract resulting in an increased Ca absorption(Reference Pastoor, Van't Klooster and Mathot118). An increase in urinary Ca excretion due to a low dietary P content could explain the increased risk for developing CaOx uroliths in cats fed diets containing a low P content (0·20 to 0·42 g/MJ ME)(Reference Lekcharoensuk, Osborne and Lulich9). On the other hand, the same study indicates that diets with a high P content (0·76 to 1·13 g/MJ ME) correlate with an increased risk of CaOx urolith formation compared with diets with moderate P content (0·66 to 0·76 g/MJ ME). Excessive amounts of P present in the gastrointestinal tract could compete with oxalate, preventing intestinal Ca complexation with oxalate, which in turn could increase the availability of free oxalate for intestinal absorption and eventually renal excretion(Reference Lekcharoensuk, Osborne and Lulich9, Reference Curhan, Willett and Speizer119, Reference Bushinsky, Bashir and Riordon120). The precise influence of dietary P on hypercalcaemia and CaOx formation in cats remains unclear and should be further studied.

Results of a retrospective case–control study revealed that cats fed diets with relatively high K contents (0·52 to 0·77 g/MJ ME) were less than half as likely (OR 0·45) to develop CaOx uroliths compared with cats fed diets with low K contents (0·23 to 0·38 g/MJ ME)(Reference Lekcharoensuk, Osborne and Lulich9). In cats, no studies have been conducted that may explain this relationship. However, in human subjects, studies have observed reduced Ca excretion after K supplementation(Reference Lemann, Pleuss and Gray121, Reference Lemann, Pleuss and Gray122). The authors of these studies suggested that the decrease in urinary Ca during K administration may be related to the natriuretic effects of K, resulting in extracellular fluid-volume contraction or to K-induced phosphate retention and/or suppression of 1,25-dihydroxyvitamin D3 synthesis(Reference Lemann, Pleuss and Gray121). Another explanation for the relationship of a higher K content with a decrease in CaOx formation is the alkalising effect of K salts, leading to a higher urine pH and therefore a lower potential for Ca and oxalate to precipitate. Whether these suggested mechanisms are effective in cats should be investigated further.

Urine pH

Although the solubility of CaOx in urine is marginally influenced by pH of 4·5 to 7·5, several epidemiological studies have consistently identified acidifying diets (containing acidifying components such as phosphoric acid, ammonium chloride or d, l-methionine) as one of the most prominent risk factors for cats(Reference Lekcharoensuk, Osborne and Lulich9, Reference Kirk, Ling and Franti10, Reference Thumchai, Lulich and Osborne13). The influence of urine pH on CaOx formation in cats was confirmed in a study feeding urine-acidifying, basal, and alkalinising diets to cats during 12 months (resulting in urine pH of 6·2 (sd 0·1), 6·8 (sd 0·2) and 7·2 (sd 0·3), respectively). Significant differences in urine saturation for CaOx were found: the highest saturation occurring in cats consuming the acidifying diet and the lowest saturation occurring in cats consuming the alkalinising diet(Reference Bartges, Kirk and Moyers123). Compared with cats, a less prominent association with dietary acidifying potential was found in dogs, especially when fed canned diets(Reference Lekcharoensuk, Osborne and Lulich124). It has been suggested that urine pH may affect the potency of CaOx crystallisation inhibitors, such as chondroitin sulfate and citrate(Reference Tiselius125). Another possible explanation is that acidifying diets increase urinary Ca excretion. Since there is a correlation between the base excess in the food and the average urine pH(Reference Kienzle, Schuknecht and Meyer126Reference Wagner, Keusch and Iben128), an acidified diet induces persistent aciduria which is associated with low-grade metabolic acidosis. This metabolic acidosis induces bone mobilisation, which results in an increased urinary Ca excretion(Reference Fettman, Coble and Hamar115, Reference Ching, Fettman and Hamar116, Reference Dow, Fettman and Smith129). Another mechanism of acidified urine to result in elevated Ca excretion is by inhibition of Ca reabsorption in the distal renal tubule(Reference McClain, Barsanti and Bartges114). Luminal protons directly inhibit transepithelial Ca reabsorption in the kidney by altering the conformation of the Ca-selective channel TRPV5 located in the apical membrane of the distal renal tubule(Reference Yeh, Kim and Jabbar130).

Although the cause of acidosis-induced hypercalcaemia in cats has not been identified, it is possible that acidosis affects the activity of TRPV5 in osteoclasts as well, which plays a critical role in bone formation and maintenance of serum Ca(Reference van der Eerden, Hoenderop and de Vries131). From the literature it appears that a dietary-induced decrease in urine pH affects the Ca excretion in the urine of cats, although the long-term effect remains questionable(Reference Fettman, Coble and Hamar115, Reference Ching, Fettman and Hamar116).

As an elevated Ca concentration in the urine can be considered as a risk factor for CaOx urolith formation, it might be reasonable to assume that a decrease in urine pH might affect the RSS of CaOx. However, some studies have claimed no correlation between urinary pH and CaOx RSS(Reference Tournier, Aladenise and Vialle132, Reference Smith, Stevenson and Markwell133). Since the RSS is thought to serve as a predictor of CaOx urolith formation(Reference Robertson, Jones and Heaton134), these findings suggest that factors other than urine pH play a role in CaOx urolith formation as well. However, it is important to note that, although the value for urinary RSS with CaOx is higher in urolith-forming dogs and cats, no prospective studies are available to confirm that a high RSS value indeed correlates with increased frequency of CaOx urolith recurrence(Reference Lulich, Osborne and Sanderson28, Reference Dru and Roudebush135).

Dietary factors influencing urine pH

Dietary protein of animal origin may decrease the base excess of the diet and increase the acid intake. As described above, a high acid intake can result in an increase in urinary Ca excretion. It can also reduce urinary citrate excretion since protons are able to associate with citrate in the intestine and kidney(Reference Dussol, Iovanna and Rotily136). This mechanism might explain why humans do have a higher risk for CaOx formation following the consumption of high amounts of animal protein(Reference Curhan, Willett and Rimm99, Reference Trinchieri, Mandressi and Luongo137). In cats, however, an opposite effect has been found. In a retrospective case–control study it was demonstrated that cats fed diets containing high amounts of protein (25·1 to 33·0 g/MJ ME) were less than half as likely (OR 0·44) to develop CaOx urolithiasis compared with cats receiving low amounts of protein (12·4 to 18·9 g/MJ ME)(Reference Lekcharoensuk, Osborne and Lulich9). A possible explanation might be that in cats the consumption of animal protein is often accompanied by stimulated water consumption, eventually resulting in an increase in urine volume, and an increased P excretion without altering Ca excretion(Reference Funaba, Hashimoto and Yamanaka20). The observed lower oxalate excretion in healthy cats fed a high-protein diet compared with a low-protein diet(Reference Zentek and Schulz92) might explain this association as well (Fig. 3).

The precise mechanism in which urinary Mg may influence CaOx formation is still largely unknown. Originally, Mg was thought to act as a mild inhibitor of CaOx crystallisation(Reference Johansson, Backman and Danielson138). Another plausible explanation is that Mg, given as alkali salts, increase the urine pH, which in turn stimulates urinary citrate excretion by the kidney, which reduces the risk of CaOx crystal formation(Reference Rattan, Sidhu and Vaidyanathan139, Reference Bonny, Rubin and Huang140).

A retrospective case–control study in cats revealed that diets with a low Mg content (22 to 43 mg/MJ ME) were associated with CaOx urolith formation(Reference Lekcharoensuk, Osborne and Lulich9). Several studies (in other species) have reported an association between low dietary Mg and CaOx urolith formation as well(Reference Rattan, Sidhu and Vaidyanathan139, Reference Schwartz, Bruce and Leslie141Reference Ogawa, Yamaguchi and Morozumi143). In addition, in human medicine an increased dietary intake of Mg salts (containing citrate) is recommended in patients suffering from CaOx urolithiasis(Reference Rattan, Sidhu and Vaidyanathan139, Reference Ettinger, Pak and Citron144, Reference Tiselius145). An additional mechanism of action is the formation of complexes between Mg and oxalate, thereby reducing the supersaturation with CaOx. However, in a study with cats fed a diet with a high Mg concentration, despite a significant increase in urinary Mg, no significant effect was observed regarding urinary CaOx crystal growth inhibition, agglomeration inhibition or solubility, compared with the base diet(Reference Reed, Markwell and Jones146). Interestingly, in the earlier mentioned retrospective case–control study, diets high in Mg content (86 to 336 mg/MJ ME) were associated with a higher risk for CaOx urolith formation compared with diets with a moderate Mg content (43–86 mg/MJ ME)(Reference Lekcharoensuk, Osborne and Lulich9). An explanation might be that in cats the contribution of dietary oxalate to urinary oxalate excretion is less prominent and therefore complexation of oxalate in the gastrointestinal tract by Mg less effective. Moreover, in cats there is no evidence that hypocitrauria is a risk factor for CaOx urolith formation.

Urinary citrate

Citrate synthesised by the kidney or derived from the diet is one of the most abundant organic anions in urine and has two main functions. First, it prevents alkaline-induced calcium phosphate stone formation by permitting base excretion without raising urine pH. Second, urinary citrate acts as a chelator of Ca and is therefore considered to be the best natural inhibitor of CaOx urolith formation(Reference Pak147). The higher the citrate concentration in the urine, the less Ca is available to form CaOx crystals. As a consequence, a deficiency of urinary citrate caused by renal or gastrointestinal disorders is often seen in humans with CaOx stone disease(Reference Allie-Hamdulay and Rodgers148, Reference Pak149). However, there is no evidence that hypocitrauria is a risk factor for CaOx urolith formation in cats. In dogs with CaOx urolithiasis, no hypocitrauria was reported(Reference Lulich, Osborne and Nagode150).

In order to increase the citrate concentration in the urine, potassium or sodium citrate is added to the majority of the CaOx urolithiasis therapeutic diets. However, there have been no studies in cats investigating the effects of dietary citrate addition on citrate concentrations in the urine or the formation of CaOx. In healthy dogs, supplementation of dietary potassium citrate did not result in a consistent increase in urinary citrate excretion(Reference Stevenson, Wrigglesworth and Smith151). In this study, only a small, but not significant, increase in urine pH was observed. This increase in urine pH might be beneficial, although the influence of the urine acidity on CaOx formation remains questionable.

Urinary glycosaminoglycans

GAG comprise another class of components affecting stone formation. They can act in two ways: GAG, chondroitin sulfate and heparin sulfate are freely excreted in the urine and can inhibit the growth of CaOx crystals. Secondly, GAG are part of the extracellular matrix and can cover the inner wall of the bladder to form a defence against microbial and crystal adherence(Reference Cao, Boeve and de Bruijn152). In cats with FIC, compared with healthy cats, a lower urinary GAG excretion has been detected, indicating that the defence against microbial and crystal adherence and inhibition of CaOx growth is decreased(Reference Buffington, Blaisdell and Binns153). Oral supplementation of GAG in order to increase the free GAG concentration in urine has been shown to have a moderate to significant beneficial effect in humans with interstitial and radial cystitis(Reference Strohmaier, Quack and Wilbert154). In a study where oral glucosamine supplementation (i.e. 125 mg N-acetyl glucosamine) was compared with a placebo control group in order to manage cats with FIC, no significant difference in urinary GAG concentration between the two groups was observed(Reference Gunn-Moore and Shenoy17). Surprisingly, the majority of the cats receiving the N-acetyl glucosamine did improve clinically, as was also the case for cats in the placebo group. According to Gunn-Moore & Shenoy(Reference Gunn-Moore and Shenoy17), the improvement in both groups can be explained by the significant decrease in urine specific gravity that was found in about 90 % of the subjects (of both treatment and placebo groups). It is likely that this positive effect was due to the fact that the owners decided to feed their cats more moist food during this study and not due to the N-acetyl glucosamine treatment.

Conclusions

Most of the dietary modifications to reduce CaOx urolith formation in cats and dogs are mainly based on data from epidemiological studies in these species and clinical studies in human subjects and rodents. Controlled studies designed to evaluate the efficacy of these dietary modifications in cats are scarce. To be able to improve the preventative measures (i.e. dietary modifications) against CaOx urolithiasis in cats, it is important to study the aetiopathogenesis of CaOx urolithiasis.

In contrast to human medicine, dietary modifications to decrease endogenous oxalate synthesis have hardly been studied in cats and future focus should examine the origin of urinary oxalate in cats, as a representative of the carnivores. The exclusive mitochondrial localisation of AGT1 in cats conforms to the notion that obligate carnivores, including domestic cats, are adapted to their natural diet, i.e. eating small mammals, containing high levels of animal protein, low levels of carbohydrate and glycolate. The observation that most commercial cat foods contain relatively high amounts of carbohydrates, often at the expense of animal protein, raises the question whether the consumption of these diets increases endogenous oxalate synthesis and in consequence the risk of CaOx urolithiasis. In addition, the contribution of exogenous oxalates to urinary oxalate excretion is unknown in cats as well. Knowledge about the dietary oxalate content in commercial feline diets, which is expected to be higher than in their natural diet, is essential in order to determine the contribution of exogenous oxalates in urinary oxalate excretion.

In-depth knowledge of feline endogenous oxalate metabolism and dietary oxalate absorption will provide a better understanding of the sharp increase in CaOx urolith prevalence in cats reported over the last few decades and provide new insights for preventative strategies. Also, based on the fact that in many human PH type I patients AGT1 is mistargeted to the mitochondria, mimicking the subcellular AGT1 distribution of cats, the cat might be a perfect research object to study endogenous oxalate synthesis in this genetic disorder.

Acknowledgements

This research received no specific grant from any funding agency in the public, commercial or not for-profit sectors.

Fig. 1 is reprinted from Osborne et al. (Reference Osborne, Lulich and Kruger1) with permission of Elsevier.

All authors contributed fundamentally to the present study. J. C. D. contributed to all facets, including literature study, scientific interpretation and manuscript preparation. E. A. P. contributed to scientific interpretation and overall manuscript preparation. J. v. B. and W. H. H. both added valuable scientific knowledge to the present review, and contributed to improve readability and layout of the manuscript.

There are no conflicts of interest.

References

1Osborne, CA, Lulich, JP, Kruger, JM, et al. . (2009) Analysis of 451,891 canine uroliths, feline uroliths, and feline urethral plugs from 1981 to 2007: perspectives from the Minnesota Urolith Center. Vet Clin North Am Small Anim Pract 39, 183197.CrossRefGoogle ScholarPubMed
2Bartges, JW, Kirk, C & Lane, IF (2004) Update: management of calcium oxalate uroliths in dogs and cats. Vet Clin North Am Small Anim Pract 34, 969987.CrossRefGoogle ScholarPubMed
3Gerber, B, Boretti, FS, Kley, S, et al. . (2005) Evaluation of clinical signs and causes of lower urinary tract disease in European cats. J Small Anim Pract 46, 571577.CrossRefGoogle ScholarPubMed
4Lund, EM, Armstrong, PJ, Kirk, CA, et al. . (1999) Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 214, 13361341.CrossRefGoogle ScholarPubMed
5Bartges, JW & Kirk, CA (2006) Nutrition and lower urinary tract disease in cats. Vet Clin North Am Small Anim Pract 36, 13611376.CrossRefGoogle ScholarPubMed
6Picavet, P, Detilleux, J, Verschuren, S, et al. . (2007) Analysis of 4495 canine and feline uroliths in the Benelux. A retrospective study: 1994–2004. J Anim Physiol Anim Nutr (Berl) 91, 247251.CrossRefGoogle ScholarPubMed
7Buffington, CA & Chew, DJ (1999) Calcium oxalate urolithiasis in cats. J Endourol 13, 659663.CrossRefGoogle ScholarPubMed
8Buffington, CA & Chew, DJ (1998) Effects of diet on cats with non-obstructive lower urinary tract disease: a review. J Anim Physiol Anim Nutr (Berl) 80, 120127.CrossRefGoogle Scholar
9Lekcharoensuk, C, Osborne, CA, Lulich, JP, et al. . (2001) Association between dietary factors and calcium oxalate and magnesium ammonium phosphate urolithiasis in cats. J Am Vet Med Assoc 219, 12281237.CrossRefGoogle ScholarPubMed
10Kirk, CA, Ling, GV, Franti, CE, et al. . (1995) Evaluation of factors associated with development of calcium oxalate urolithiasis in cats. J Am Vet Med Assoc 207, 14291434.CrossRefGoogle ScholarPubMed
11Lulich, JP & Osborne, CA (2007) Feline urolithiasis: understanding the shift in urolith type. In 2007 Nestle Purina Nutrition Forum, pp. 5459. http://www.purina.vet.breederclub.it/eventivnn/07%20Forum%20Proceedings.pdf (accessed 4 January 2011).Google Scholar
12Lekcharoensuk, C, Lulich, JP, Osborne, CA, et al. . (2000) Association between patient-related factors and risk of calcium oxalate and magnesium ammonium phosphate urolithiasis in cats. J Am Vet Med Assoc 217, 520525.CrossRefGoogle ScholarPubMed
13Thumchai, R, Lulich, J, Osborne, CA, et al. . (1996) Epizootiologic evaluation of urolithiasis in cats: 3,498 cases (1982–1992). J Am Vet Med Assoc 208, 547551.CrossRefGoogle ScholarPubMed
14Markwell, PJ, Buffington, CT & Smith, BH (1998) The effect of diet on lower urinary tract diseases in cats. J Nutr 128, 2753S2757S.CrossRefGoogle ScholarPubMed
15Gaskell, GC (1989) The role of fluid in the feline urological syndrome. In Nutrition of the Dog and Cat, pp. 353356 [Rivers, JPW and Burger, IH, editors]. Cambridge: Cambridge University Press.Google Scholar
16Burger, IH & Smith, PM (1987) Effects of diet on the urine characteristics of the cat. In Nutrition, Malnutrition and Dietetics in the Dog and Cat: Proceedings of an International Symposium, pp. 7173[ATB Edney, editor]. London: British Veterinary Association.Google Scholar
17Gunn-Moore, DA & Shenoy, CM (2004) Oral glucosamine and the management of feline idiopathic cystitis. J Feline Med Surg 6, 219225.CrossRefGoogle ScholarPubMed
18Buffington, CA (1994) Lower urinary tract disease in cats – new problems, new paradigms. J Nutr 124, 2643S2651S.CrossRefGoogle ScholarPubMed
19Funaba, M, Yamate, T, Hashida, Y, et al. . (2003) Effects of a high-protein diet versus dietary supplementation with ammonium chloride on struvite crystal formation in urine of clinically normal cats. Am J Vet Res 64, 10591064.CrossRefGoogle ScholarPubMed
20Funaba, M, Hashimoto, M, Yamanaka, C, et al. . (1996) Effects of a high-protein diet on mineral metabolism and struvite activity product in clinically normal cats. Am J Vet Res 57, 17261732.CrossRefGoogle ScholarPubMed
21Borghi, L, Meschi, T, Schianchi, T, et al. . (1999) Urine volume: stone risk factor and preventive measure. Nephron 81, Suppl. 1, 3137.CrossRefGoogle ScholarPubMed
22Chandler, ML (2008) Pet food safety: sodium in pet foods. Top Companion Anim Med 23, 148153.CrossRefGoogle ScholarPubMed
23Castenmiller, JJ, Mensink, RP, van der Heijden, L, et al. . (1985) The effect of dietary sodium on urinary calcium and potassium excretion in normotensive men with different calcium intakes. Am J Clin Nutr 41, 5260.CrossRefGoogle ScholarPubMed
24Kok, DJ, Iestra, JA, Doorenbos, CJ, et al. . (1990) The effect of dietary excesses in animal protein and sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 71, 861867.CrossRefGoogle ScholarPubMed
25Sakhaee, K, Harvey, JA, Padalino, PK, et al. . (1993) The potential role of salt abuse on the risk for kidney stone formation. J Urol 150, 310312.CrossRefGoogle ScholarPubMed
26Massey, LK & Whiting, SJ (1996) Dietary salt, urinary calcium, and bone loss. J Bone Miner Res 11, 731736.CrossRefGoogle ScholarPubMed
27Biourge, V, Devois, C, Morice, G, et al. . (2001) Increased dietary NaCl significantly increases urine volume but does not increase urinary calcium oxalate supersaturation in healthy cats. J Vet Intern Med, 301.Google Scholar
28Lulich, JP, Osborne, CA & Sanderson, SL (2005) Effects of dietary supplementation with sodium chloride on urinary relative supersaturation with calcium oxalate in healthy dogs. Am J Vet Res 66, 319324.CrossRefGoogle ScholarPubMed
29Stevenson, AE, Hynds, WK & Markwell, PJ (2003) Effect of dietary moisture and sodium content on urine composition and calcium oxalate relative supersaturation in healthy miniature schnauzers and labrador retrievers. Res Vet Sci 74, 145151.CrossRefGoogle ScholarPubMed
30Hawthorne, AJ & Markwell, PJ (2004) Dietary sodium promotes increased water intake and urine volume in cats. J Nutr 134, 2128S2129S.CrossRefGoogle ScholarPubMed
31Tournier, C, Aladenise, S, Vialle, S, et al. (2006) The effect of dietary sodium on urine composition and calcium oxalate relative supersaturation in healthy cats. In Proceedings of the 10th International Congress of ESVCN, p. 189. http://www.royal-canin.de/fileadmin/downloads/VMM_Na_and_CaOx_ESVCN_2006_poster.pdf (accessed 4 January 2011).Google Scholar
32Xu, H, Laflamme, DP & Long, GL (2009) Effects of dietary sodium chloride on health parameters in mature cats. J Feline Med Surg 11, 435441.CrossRefGoogle ScholarPubMed
33Luckschander, N, Iben, C, Hosgood, G, et al. . (2004) Dietary NaCl does not affect blood pressure in healthy cats. J Vet Intern Med 18, 463467.CrossRefGoogle Scholar
34Borsatti, A (1991) Calcium oxalate nephrolithiasis: defective oxalate transport. Kidney Int 39, 12831298.CrossRefGoogle ScholarPubMed
35Finlayson, B (1978) Physicochemical aspects of urolithiasis. Kidney Int 13, 344360.CrossRefGoogle ScholarPubMed
36Chai, W, Liebman, M, Kynast-Gales, S, et al. . (2004) Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis 44, 10601069.CrossRefGoogle ScholarPubMed
37Massey, LK (2007) Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc 107, 11911194.CrossRefGoogle ScholarPubMed
38Siener, R, Honow, R, Voss, S, et al. . (2006) Oxalate content of cereals and cereal products. J Agric Food Chem 54, 30083011.CrossRefGoogle ScholarPubMed
39Committee on Examining the Safety of Supplements for Horses, Dogs and Cats; National Research Council (2009) Factors affecting animal dietary supplement safety; section Biological factors affecting animal dietary supplement safety/natural diet. In Safety of Dietary Supplements for Horses, Dogs and Cats, pp. 3637. Washington, DC: The National Academies Press.Google Scholar
40Plantinga, EA, Bosch, G & Hendriks, WH (2010) Feline paleolithic nutrition: a consideration of its nature and its implications for digestive physiology. Br J Nutr (In the Press).Google Scholar
41von Unruh, GE, Voss, S & Sauerbruch, T (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 169, 687690.CrossRefGoogle ScholarPubMed
42Holmes, RP, Goodman, HO & Assimos, DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59, 270276.CrossRefGoogle ScholarPubMed
43Stevenson, AE, Hynds, WK & Markwell, PJ (2003) The relative effects of supplemental dietary calcium and oxalate on urine composition and calcium oxalate relative supersaturation in healthy adult dogs. Res Vet Sci 75, 3341.CrossRefGoogle ScholarPubMed
44Stevenson, AE, Blackburn, JM, Markwell, PJ, et al. . (2004) Nutrient intake and urine composition in calcium oxalate stone-forming dogs: comparison with healthy dogs and impact of dietary modification. Vet Ther 5, 218231.Google ScholarPubMed
45Morozumi, M, Hossain, RZ, Yamakawa, K, et al. . (2006) Gastrointestinal oxalic acid absorption in calcium-treated rats. Urol Res 34, 168172.CrossRefGoogle ScholarPubMed
46Liebman, M & Chai, W (1997) Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr 65, 14531459.CrossRefGoogle ScholarPubMed
47Liebman, M & Costa, G (2000) Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 163, 15651569.CrossRefGoogle ScholarPubMed
48Masai, M, Ito, H & Kotake, T (1995) Effect of dietary intake on urinary oxalate excretion in calcium renal stone formers. Br J Urol 76, 692696.CrossRefGoogle ScholarPubMed
49Naya, Y, Ito, H, Masai, M, et al. . (2002) Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU Int 89, 842846.CrossRefGoogle ScholarPubMed
50Sidhu, H, Allison, MJ, Chow, JM, et al. . (2001) Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 166, 14871491.CrossRefGoogle Scholar
51Troxel, SA, Sidhu, H, Kaul, P, et al. . (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17, 173176.CrossRefGoogle ScholarPubMed
52Weese, JS & Palmer, A (2009) Presence of Oxalobacter formigenes in the stool of healthy dogs. Vet Microbiol 137, 412413.CrossRefGoogle ScholarPubMed
53Weese, JS, Weese, HE & Rousseau, J (2009) Identification of Oxalobacter formigenes in the faeces of healthy cats. Lett Appl Microbiol 49, 800802.CrossRefGoogle ScholarPubMed
54Weese, JS, Weese, HE, Yuricek, L, et al. . (2004) Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol 101, 161166.CrossRefGoogle ScholarPubMed
55Lulich, JP, Osborne, CA, Thumchai, R, et al. . (1999) Epidemiology of canine calcium oxalate uroliths. Identifying risk factors. Vet Clin North Am Small Anim Pract 29, 113122, xi.CrossRefGoogle ScholarPubMed
56Williams, HE (1978) Oxalic acid and the hyperoxaluric syndromes. Kidney Int 13, 410417.CrossRefGoogle ScholarPubMed
57Ogawa, Y, Miyazato, T & Hatano, T (2000) Oxalate and urinary stones. World J Surg 24, 11541159.CrossRefGoogle ScholarPubMed
58Holmes, RP, Knight, J & Assimos, DG (2007) Origin of urinary oxalate. Renal Stone Dis 900, 176182.Google Scholar
59Yu, S & Gross, K (2005) Moderate dietary vitamin C supplement does not affect urinary oxalate concentrations in cats. J Anim Physiol Anim Nutr 89, 428429.CrossRefGoogle Scholar
60Farinelli, MP & Richardson, KE (1983) Oxalate synthesis from [14C1]glycollate and [14C1]glyoxylate in the hepatectomized rat. Biochim Biophys Acta 757, 814.CrossRefGoogle ScholarPubMed
61Behnam, JT, Williams, EL, Brink, S, et al. . (2006) Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells. Biochem J 394, 409416.CrossRefGoogle ScholarPubMed
62Holmes, RP, Ambrosius, WT & Assimos, DG (2005) Dietary oxalate loads and renal oxalate handling. J Urol 174, 943947.CrossRefGoogle ScholarPubMed
63Knight, J, Holmes, RP & Assimos, DG (2007) Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 35, 111117.CrossRefGoogle ScholarPubMed
64Danpure, CJ, Guttridge, KM, Fryer, P, et al. . (1990) Subcellular distribution of hepatic alanine:glyoxylate aminotransferase in various mammalian species. J Cell Sci 97, 669678.CrossRefGoogle ScholarPubMed
65Bai, SC, Sampson, DA, Morris, JG, et al. . (1989) Vitamin B-6 requirement of growing kittens. J Nutr 119, 10201027.CrossRefGoogle ScholarPubMed
66Williams, HE & Smith, LH Jr (1968) l-Glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med 278, 233238.CrossRefGoogle ScholarPubMed
67Mistry, J, Danpure, CJ & Chalmers, RA (1988) Hepatic d-glycerate dehydrogenase and glyoxylate reductase deficiency in primary hyperoxaluria type 2. Biochem Soc Trans 16, 626627.CrossRefGoogle Scholar
68Danpure, CJ, Jennings, PR, Mistry, J, et al. . (1989) Enzymological characterization of a feline analogue of primary hyperoxaluria type 2: a model for the human disease. J Inherit Metab Dis 12, 403414.CrossRefGoogle Scholar
69Mdluli, K, Booth, MP, Brady, RL, et al. . (2005) A preliminary account of the properties of recombinant human glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism. Biochim Biophys Acta 1753, 209216.CrossRefGoogle ScholarPubMed
70Cramer, SD, Ferree, PM, Lin, K, et al. . (1999) The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 8, 20632069.CrossRefGoogle ScholarPubMed
71De Lorenzi, D, Bernardini, M & Pumarola, M (2005) Primary hyperoxaluria (l-glyceric aciduria) in a cat. J Feline Med Surg 7, 357361.CrossRefGoogle ScholarPubMed
72McKerrell, RE, Blakemore, WF, Heath, MF, et al. . (1989) Primary hyperoxaluria (l-glyceric aciduria) in the cat: a newly recognised inherited disease. Vet Rec 125, 3134.CrossRefGoogle Scholar
73Danpure, CJ, Fryer, P, Jennings, PR, et al. . (1994) Evolution of alanine:glyoxylate aminotransferase 1 peroxisomal and mitochondrial targeting. A survey of its subcellular distribution in the livers of various representatives of the classes Mammalia, Aves and Amphibia. Eur J Cell Biol 64, 295313.Google ScholarPubMed
74Lumb, MJ, Purdue, PE & Danpure, CJ (1994) Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the feline gene. Eur J Biochem 221, 5362.CrossRefGoogle ScholarPubMed
75Danpure, CJ (2006) Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Biochim Biophys Acta 1763, 17761784.CrossRefGoogle ScholarPubMed
76Oatey, PB, Lumb, MJ & Danpure, CJ (1996) Molecular basis of the variable mitochondrial and peroxisomal localisation of alanine-glyoxylate aminotransferase. Eur J Biochem 241, 374385.CrossRefGoogle ScholarPubMed
77Birdsey, GM, Lewin, J, Cunningham, AA, et al. . (2004) Differential enzyme targeting as an evolutionary adaptation to herbivory in carnivora. Mol Biol Evol 21, 632646.CrossRefGoogle ScholarPubMed
78Purdue, PE, Lumb, MJ & Danpure, CJ (1992) Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the marmoset and rabbit genes. Eur J Biochem 207, 757766.CrossRefGoogle ScholarPubMed
79Holmes, RP & Assimos, DG (1998) Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol 160, 16171624.CrossRefGoogle ScholarPubMed
80Gambardella, RL & Richardson, KE (1978) The formation of oxalate from hydroxypyruvate, serine, glycolate and glyoxylate in the rat. Biochim Biophys Acta 544, 315328.CrossRefGoogle ScholarPubMed
81Gambardella, RL & Richardson, KE (1977) The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat. Biochim Biophys Acta 499, 156168.CrossRefGoogle ScholarPubMed
82Ribaya, JD & Gershoff, SN (1981) Effects of hydroxyproline and vitamin B-6 on oxalate synthesis in rats. J Nutr 111, 12311239.CrossRefGoogle ScholarPubMed
83Takayama, T, Fujita, K, Suzuki, K, et al. . (2003) Control of oxalate formation from l-hydroxyproline in liver mitochondria. J Am Soc Nephrol 14, 939946.CrossRefGoogle ScholarPubMed
84Ribaya-Mercado, JD & Gershoff, SN (1984) Effects of sugars and vitamin B-6 deficiency on oxalate synthesis in rats. J Nutr 114, 14471453.CrossRefGoogle ScholarPubMed
85Nguyen, UN, Dumoulin, G, Henriet, MT, et al. . (1998) Aspartame ingestion increases urinary calcium, but not oxalate excretion, in healthy subjects. J Clin Endocrinol Metab 83, 165168.CrossRefGoogle Scholar
86Nguyen, NU, Dumoulin, G, Henriet, MT, et al. . (1998) Effects of i.v. insulin bolus on urinary calcium and oxalate excretion in healthy subjects. Horm Metab Res 30, 222226.CrossRefGoogle ScholarPubMed
87Nguyen, NU, Dumoulin, G, Wolf, JP, et al. . (1989) Urinary calcium and oxalate excretion during oral fructose or glucose load in man. Horm Metab Res 21, 9699.CrossRefGoogle ScholarPubMed
88Nguyen, NU, Dumoulin, G, Henriet, MT, et al. . (1993) Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners. J Clin Endocrinol Metab 77, 388392.Google ScholarPubMed
89Nguyen, NU, Dumoulin, G, Henriet, MT, et al. . (1995) Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res 27, 155158.CrossRefGoogle ScholarPubMed
90Knight, J, Jiang, J, Assimos, DG, et al. . (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70, 19291934.CrossRefGoogle ScholarPubMed
91Knight, J, Easter, LH, Neiberg, R, et al. . (2009) Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res 37, 6368.CrossRefGoogle Scholar
92Zentek, J & Schulz, A (2004) Urinary composition of cats is affected by the source of dietary protein. J Nutr 134, 2162S2165S.CrossRefGoogle ScholarPubMed
93Laser Reutersward, A, Asp, NG & Bjork, I (1985) Protein digestibility of pigskin and bovine tendon in rats. J Food Technol 20, 745752.CrossRefGoogle Scholar
94Mustillo, M, Bartges, JW, Kirk, CA, et al. . (2008) Influence of a low carbohydrate, dry formulated diet on urinary saturation for calcium oxalate and struvite in healthy adult female cats. ACVIM Forum 2008. J Vet Intern Med 22, 733.Google Scholar
95Tanaka, A, Inoue, A, Takeguchi, A, et al. . (2005) Comparison of expression of glucokinase gene and activities of enzymes related to glucose metabolism in livers between dog and cat. Vet Res Commun 29, 477485.CrossRefGoogle ScholarPubMed
96Rofe, AM, Thomas, DW, Edwards, RG, et al. . (1977) (14C)Oxalate synthesis from (U-14C)xylitol: in vivo and in vitro studies. Biochem Med 18, 440451.CrossRefGoogle ScholarPubMed
97Yanagawa, M, Maeda-Nakai, E, Yamakawa, K, et al. . (1990) The formation of oxalate from glycolate in rat and human liver. Biochim Biophys Acta 1036, 2433.CrossRefGoogle ScholarPubMed
98Morris, JG (2002) Idiosyncratic nutrient requirements for cats appear to be diet-induced evolutionary adaptations. Nutr Res Rev 15, 153168.CrossRefGoogle ScholarPubMed
99Curhan, GC, Willett, WC, Rimm, EB, et al. . (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328, 833838.CrossRefGoogle ScholarPubMed
100Nguyen, QV, Kalin, A, Drouve, U, et al. . (2001) Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kidney Int 59, 22732281.CrossRefGoogle ScholarPubMed
101Noguchi, T, Okuno, E, Takada, Y, et al. . (1978) Characteristics of hepatic alanine-glyoxylate aminotransferase in different mammalian species. Biochem J 169, 113122.CrossRefGoogle ScholarPubMed
102Takada, Y, Mori, T & Noguchi, T (1984) The effect of vitamin B6 deficiency on alanine:glyoxylate aminotransferase isoenzymes in rat liver. Arch Biochem Biophys 229, 16.CrossRefGoogle ScholarPubMed
103Teerajetgul, Y, Hossain, RZ, Yamakawa, K, et al. . (2007) Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats. Urol Res 35, 173178.CrossRefGoogle ScholarPubMed
104Nishijima, S, Sugaya, K, Morozumi, M, et al. . (2003) Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol 169, 683686.CrossRefGoogle ScholarPubMed
105Ogawa, Y, Hossain, RZ, Ogawa, T, et al. . (2007) Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous l-hydroxyproline loading in rats. Urol Res 35, 1521.CrossRefGoogle ScholarPubMed
106Bai, SC, Sampson, DA, Morris, JG, et al. . (1991) The level of dietary protein affects the vitamin B-6 requirement of cats. J Nutr 121, 10541061.CrossRefGoogle ScholarPubMed
107Auer, BL, Auer, D & Rodgers, AL (1998) Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 28, 695700.CrossRefGoogle ScholarPubMed
108Moyad, MA, Combs, MA, Crowley, DC, et al. . (2009) Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding. Urol Nurs 29, 95102.Google ScholarPubMed
109Massey, LK, Liebman, M & Kynast-Gales, SA (2005) Ascorbate increases human oxaluria and kidney stone risk. J Nutr 135, 16731677.CrossRefGoogle ScholarPubMed
110Baxmann, AC, De O G Mendonça, C & Heilberg, IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 63, 10661071.CrossRefGoogle ScholarPubMed
111Subcommittee on Dog and Cat Nutrition, Committee on Animal Nutrition & National Research Council (2006) Vitamins; section Ascorbic acid. In Nutrient Requirements of Dogs and Cats, pp. 234235. Washington, DC: The National Academies Press.Google Scholar
112Osborne, CA, Lulich, JP, Thumchai, R, et al. . (1996) Feline urolithiasis. Etiology and pathophysiology. Vet Clin North Am Small Anim Pract 26, 217232.Google ScholarPubMed
113Midkiff, AM, Chew, DJ, Randolph, JF, et al. . (2000) Idiopathic hypercalcemia in cats. J Vet Intern Med 14, 619626.CrossRefGoogle ScholarPubMed
114McClain, HM, Barsanti, JA & Bartges, JW (1999) Hypercalcemia and calcium oxalate urolithiasis in cats: a report of five cases. J Am Anim Hosp Assoc 35, 297301.CrossRefGoogle Scholar
115Fettman, MJ, Coble, JM, Hamar, DW, et al. . (1992) Effect of dietary phosphoric acid supplementation on acid–base balance and mineral and bone metabolism in adult cats. Am J Vet Res 53, 21252135.CrossRefGoogle ScholarPubMed
116Ching, SV, Fettman, MJ, Hamar, DW, et al. . (1989) The effect of chronic dietary acidification using ammonium chloride on acid–base and mineral metabolism in the adult cat. J Nutr 119, 902915.CrossRefGoogle ScholarPubMed
117Penniston, KL & Nakada, SY (2009) Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation. Urology 73, 484489.CrossRefGoogle ScholarPubMed
118Pastoor, FJ, Van't Klooster, AT, Mathot, JN, et al. . (1995) Increasing phosphorus intake reduces urinary concentrations of magnesium and calcium in adult ovariectomized cats fed purified diets. J Nutr 125, 13341341.Google ScholarPubMed
119Curhan, GC, Willett, WC, Speizer, FE, et al. . (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126, 497504.CrossRefGoogle ScholarPubMed
120Bushinsky, DA, Bashir, MA, Riordon, DR, et al. . (1999) Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55, 602612.CrossRefGoogle ScholarPubMed
121Lemann, J Jr, Pleuss, JA & Gray, RW (1993) Potassium causes calcium retention in healthy adults. J Nutr 123, 16231626.CrossRefGoogle ScholarPubMed
122Lemann, J Jr, Pleuss, JA, Gray, RW, et al. . (1991) Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected]. Kidney Int 39, 973983.CrossRefGoogle ScholarPubMed
123Bartges, JW, Kirk, CA & Moyers, T (2004) Influence of alkalinization and acidification on urine saturation with calcium oxalate and struvite and bone mineral density in healthy cats. Urol Res 32, 172.Google Scholar
124Lekcharoensuk, C, Osborne, CA, Lulich, JP, et al. . (2002) Associations between dry dietary factors and canine calcium oxalate uroliths. Am J Vet Res 63, 330337.CrossRefGoogle ScholarPubMed
125Tiselius, HG (1981) The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Br J Urol 53, 470474.CrossRefGoogle ScholarPubMed
126Kienzle, E, Schuknecht, A & Meyer, H (1991) Influence of food composition on the urine pH in cats. J Nutr 121, S87S88.CrossRefGoogle ScholarPubMed
127Kienzle, E & Wilms-Eilers, S (1994) Struvite diet in cats: effect of ammonium chloride and carbonates on acid base balance of cats. J Nutr 124, 2652S2659S.CrossRefGoogle ScholarPubMed
128Wagner, E, Keusch, C & Iben, C (2006) Influence of the feed base excess on urine parameters in cats. J Anim Physiol Anim Nutr (Berl) 90, 1924.CrossRefGoogle ScholarPubMed
129Dow, SW, Fettman, MJ, Smith, KR, et al. . (1990) Effects of dietary acidification and potassium depletion on acid–base balance, mineral metabolism and renal function in adult cats. J Nutr 120, 569578.CrossRefGoogle ScholarPubMed
130Yeh, BI, Kim, YK, Jabbar, W, et al. . (2005) Conformational changes of pore helix coupled to gating of TRPV5 by protons. EMBO J 24, 32243234.CrossRefGoogle ScholarPubMed
131van der Eerden, BC, Hoenderop, JG, de Vries, TJ, et al. . (2005) The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc Natl Acad Sci U S A 102, 1750717512.CrossRefGoogle ScholarPubMed
132Tournier, C, Aladenise, S, Vialle, S, et al. . (2006) The effect of urinary pH on calcium oxalate relative supersaturation in healthy cats. Royal Canin, Research Center, Aimargues (France). http://www.royal-canin.de/fileadmin/downloads/VMM_pH_and_CaOX_ESVCN_2006_poster.pdf (accessed 4 January 2011).Google Scholar
133Smith, BH, Stevenson, AE & Markwell, PJ (1998) Urinary relative supersaturations of calcium oxalate and struvite in cats are influenced by diet. J Nutr 128, 2763S2764S.CrossRefGoogle ScholarPubMed
134Robertson, WG, Jones, JS, Heaton, MA, et al. . (2002) Predicting the crystallization potential of urine from cats and dogs with respect to calcium oxalate and magnesium ammonium phosphate (struvite). J Nutr 132, 1637S1641S.CrossRefGoogle ScholarPubMed
135Dru, FS & Roudebush, P (2007) Evidence-based management of feline lower urinary tract disease. Vet Clin North Am Small Anim Pract 37, 533558.Google Scholar
136Dussol, B, Iovanna, C, Rotily, M, et al. . (2008) A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract 110, c185c194.CrossRefGoogle ScholarPubMed
137Trinchieri, A, Mandressi, A, Luongo, P, et al. . (1991) The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol 67, 230236.CrossRefGoogle ScholarPubMed
138Johansson, G, Backman, U, Danielson, BG, et al. . (1980) Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124, 770774.CrossRefGoogle ScholarPubMed
139Rattan, V, Sidhu, H, Vaidyanathan, S, et al. . (1994) Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers. Urol Res 22, 161165.CrossRefGoogle ScholarPubMed
140Bonny, O, Rubin, A, Huang, CL, et al. . (2008) Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol 19, 15301537.CrossRefGoogle ScholarPubMed
141Schwartz, BF, Bruce, J, Leslie, S, et al. . (2001) Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol 15, 233235.CrossRefGoogle ScholarPubMed
142Schwille, PO, Schmiedl, A, Herrmann, U, et al. . (1999) Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis. Urol Res 27, 117126.CrossRefGoogle ScholarPubMed
143Ogawa, Y, Yamaguchi, K & Morozumi, M (1990) Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats. J Urol 144, 385389.CrossRefGoogle ScholarPubMed
144Ettinger, B, Pak, CY, Citron, JT, et al. . (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158, 20692073.CrossRefGoogle ScholarPubMed
145Tiselius, HG (2001) Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 88, 158168.CrossRefGoogle ScholarPubMed
146Reed, CF, Markwell, PJ & Jones, CA (2000) The effect of oral magnesium salt administration on urinary calcium oxalate crystallization and agglomeration in cats. J Vet Intern Med 14, 383383.Google Scholar
147Pak, CY (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18, 624637.CrossRefGoogle ScholarPubMed
148Allie-Hamdulay, S & Rodgers, AL (2005) Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial. Urol Res 33, 116124.CrossRefGoogle ScholarPubMed
149Pak, CY (1994) Citrate and renal calculi: an update. Miner Electrolyte Metab 20, 371377.Google ScholarPubMed
150Lulich, JP, Osborne, CA, Nagode, LA, et al. . (1991) Evaluation of urine and serum metabolites in miniature schnauzers with calcium oxalate urolithiasis. Am J Vet Res 52, 15831590.CrossRefGoogle ScholarPubMed
151Stevenson, AE, Wrigglesworth, DJ, Smith, BH, et al. . (2000) Effects of dietary potassium citrate supplementation on urine pH and urinary relative supersaturation of calcium oxalate and struvite in healthy dogs. Am J Vet Res 61, 430435.CrossRefGoogle ScholarPubMed
152Cao, LC, Boeve, ER, de Bruijn, WC, et al. . (1997) Glycosaminoglycans and semisynthetic sulfated polysaccharides: an overview of their potential application in treatment of patients with urolithiasis. Urology 50, 173183.CrossRefGoogle ScholarPubMed
153Buffington, CA, Blaisdell, JL, Binns, SP Jr, et al. . (1996) Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis. J Urol 155, 18011804.CrossRefGoogle ScholarPubMed
154Strohmaier, WL, Quack, M, Wilbert, DM, et al. . (1989) Therapy of interstitial and radiogenic cystitis with d-glucosamine. Helv Chir Acta 56, 323325.Google ScholarPubMed
155Booth, MP, Conners, R, Rumsby, G, et al. . (2006) Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase. J Mol Biol 360, 178189.CrossRefGoogle ScholarPubMed
156Genolet, R, Kersten, S, Braissant, O, et al. . (2005) Promoter rearrangements cause species-specific hepatic regulation of the glyoxylate reductase/hydroxypyruvate reductase gene by the peroxisome proliferator-activated receptor α. J Biol Chem 280, 2414324152.CrossRefGoogle ScholarPubMed
157Xue, HH, Sakaguchi, T, Fujie, M, et al. . (1999) Flux of the l-serine metabolism in rabbit, human, and dog livers. Substantial contributions of both mitochondrial and peroxisomal serine:pyruvate/alanine:glyoxylate aminotransferase. J Biol Chem 274, 1602816033.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Feline urolith distribution in the USA from 1981 until 2007(1): magnesium ammonium phosphate hexahydrate (□); calcium oxalate (■); calcium phosphate (); purine (); matrix (); other ().

Figure 1

Fig. 2 Schematic model of dietary risk factors likely to increase calcium oxalate urolith formation in cats. GAG, glycosaminoglycan. * This box contains dietary factors affecting the availability of exogenous oxalate for absorption in the gastrointestinal tract. † This box contains dietary factors affecting endogenous oxalate synthesis.

Figure 2

Fig. 3 Proposed metabolic pathways of de novo oxalate synthesis via glyoxylate metabolism. Major metabolic conversions that are considered prominent in the feline hepatocytes when precursors from a carnivorous and omnivorous diet are present are shown in panels A and B, respectively. Metabolic conversions expected to play a major role are indicated by thick arrows. Metabolic conversions expected to play a minor role are indicated by dashed arrows. Essential metabolic conversions in situation A are indicated with I, II, III or IV, meaning: I, conversion of glyoxylate into oxalate catalysed by cytosolic l-lactate dehydrogenase (l-LDH)(61,69); II, conversion of glyoxylate into l-glycine catalysed by alanine:glyoxylate aminotransferase 1 (AGT1)(64,74,75,82,83,92,100,101,105); III, conversion of glyoxylate into glycolate catalysed by glyoxylate reductase/hydroxypyruvate reductase (GR/HPR)(67,68,69,72,155,156); IV, conversion of hydroxypyruvate into d-glycerate catalysed by glyoxylate reductase/hydroxypyruvate reductase(67,68,69,72,155,156). Essential metabolic conversions in situation B are indicated with Ia–d, II, III and IV, meaning: Ia, conversion of cytosolic d-fructose, d-glucose and d-galactose into d-glycerate(86,87,89); Ib, conversion of d-glycerate into hydroxypyruvate; Ic, conversion of hydroxypyruvate into glycolaldehyde(80); Id, conversion of glycolaldehyde into glycolate(80); II, conversion of peroxisomal glycolate into oxalate catalysed by glycolate dehydrogenase (GD)(97); III, conversion of peroxisomal glycolate into glyoxylate catalysed by glycolate oxidase (GO)(97); IV, conversion of glyoxylate into l-glycine catalysed by alanine:glyoxylate aminotransferase 1(64,74,75,101,157).